Plasma sphingolipids and depressive symptoms in coronary artery disease
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma sphingolipids and depressive symptoms in coronary artery disease
Authors
Keywords
-
Journal
Brain and Behavior
Volume 7, Issue 11, Pages e00836
Publisher
Wiley
Online
2017-09-27
DOI
10.1002/brb3.836
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reevaluating the Efficacy and Predictability of Antidepressant Treatments
- (2017) Adam M. Chekroud et al. JAMA Psychiatry
- Plasma lipidomics reveals potential lipid markers of major depressive disorder
- (2016) Xinyu Liu et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Sphingolipids Contribute to Human Atherosclerotic Plaque InflammationHighlights
- (2016) Andreas Edsfeldt et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Trajectories of Stress, Depressive Symptoms, and Immunity in Cancer Survivors: Diagnosis to 5 Years
- (2016) Barbara L. Andersen et al. CLINICAL CANCER RESEARCH
- Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol
- (2016) Reijo Laaksonen et al. EUROPEAN HEART JOURNAL
- Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer’s Disease
- (2016) Yi Xing et al. JOURNAL OF ALZHEIMERS DISEASE
- Metabolomic profile for the early detection of coronary artery disease by using UPLC-QTOF/MS
- (2016) Xiaobao Xu et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Depression and coronary heart disease
- (2016) Robert M. Carney et al. Nature Reviews Cardiology
- Brain membrane lipids in major depression and anxiety disorders
- (2015) Christian P. Müller et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Depression is not a consistent syndrome: An investigation of unique symptom patterns in the STAR*D study
- (2015) Eiko I. Fried et al. JOURNAL OF AFFECTIVE DISORDERS
- A central role for the acid sphingomyelinase/ceramide system in neurogenesis and major depression
- (2015) Erich Gulbins et al. JOURNAL OF NEUROCHEMISTRY
- Statins, cognition, and dementia—systematic review and methodological commentary
- (2015) Melinda C. Power et al. Nature Reviews Neurology
- Demonstrating the Role of Anticholinergic Activity in a Mood Disorder
- (2015) Koji Hori et al. Neurodegenerative Diseases
- Sphingolipids in Major Depression
- (2015) Peter L. Jernigan et al. NEUROSIGNALS
- Alteration in Metabolic Signature and Lipid Metabolism in Patients with Angina Pectoris and Myocardial Infarction
- (2015) Ju Yeon Park et al. PLoS One
- Depression and cardiovascular disease
- (2015) Steven M. Bradley et al. TRENDS IN CARDIOVASCULAR MEDICINE
- The use of statins for the treatment of depression in patients with acute coronary syndrome
- (2015) S W Kim et al. Translational Psychiatry
- Depression as a Risk Factor for Poor Prognosis Among Patients With Acute Coronary Syndrome: Systematic Review and Recommendations
- (2014) Judith H. Lichtman et al. CIRCULATION
- Dose-Dependent Effects of Rosuvastatin on the Plasma Sphingolipidome and Phospholipidome in the Metabolic Syndrome
- (2014) Theodore W. K. Ng et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Elevated Plasma Ceramides in Depression
- (2014) Patricia Gracia-Garcia et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease
- (2014) Michelle M. Mielke et al. NEUROBIOLOGY OF AGING
- The ceramide system as a novel antidepressant target
- (2014) Johannes Kornhuber et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Sex and Age Differences in the Relation of Depressive Symptoms With Blood Pressure
- (2013) M. T. Shah et al. AMERICAN JOURNAL OF HYPERTENSION
- Depression and cardiovascular disease: a clinical review
- (2013) D. L. Hare et al. EUROPEAN HEART JOURNAL
- Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasingde novosynthesis of long-chain ceramides
- (2013) Resat Cinar et al. HEPATOLOGY
- Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs
- (2013) Erich Gulbins et al. NATURE MEDICINE
- Plasma Ceramide and Glucosylceramide Metabolism Is Altered in Sporadic Parkinson's Disease and Associated with Cognitive Impairment: A Pilot Study
- (2013) Michelle M. Mielke et al. PLoS One
- Ceramides predict verbal memory performance in coronary artery disease patients undertaking exercise: a prospective cohort pilot study
- (2013) Mahwesh Saleem et al. BMC Geriatrics
- The relevance of oxidative stress status in first episode and recurrent depression
- (2012) Cristinel Stefanescu et al. JOURNAL OF AFFECTIVE DISORDERS
- Plasma phosphatidylcholine and sphingomyelin concentrations are associated with depression and anxiety symptoms in a Dutch family-based lipidomics study
- (2012) Ayşe Demirkan et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression
- (2012) F Lamers et al. MOLECULAR PSYCHIATRY
- Omega-3 supplementation lowers inflammation and anxiety in medical students: A randomized controlled trial
- (2011) Janice K. Kiecolt-Glaser et al. BRAIN BEHAVIOR AND IMMUNITY
- Depression and Cardiac Disease
- (2011) Christopher M. Celano et al. Cardiology in Review
- S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease
- (2011) Kelley M Argraves et al. Lipids in Health and Disease
- Increasing off-label use of antipsychotic medications in the United States, 1995-2008
- (2011) G. C. Alexander et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics
- (2011) Xianlin Han et al. PLoS One
- Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease
- (2010) Katherine J. E. Sattler et al. BASIC RESEARCH IN CARDIOLOGY
- Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): A Novel Pharmacological Group of Drugs with Broad Clinical Applications
- (2010) Johannes Kornhuber et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Major Depressive Disorder Predicts Completion, Adherence, and Outcomes in Cardiac Rehabilitation
- (2010) Walter Swardfager et al. JOURNAL OF CLINICAL PSYCHIATRY
- Plasma and Erythrocyte Fatty Acid Patterns in Patients with Recurrent Depression: A Matched Case-Control Study
- (2010) Johanna Assies et al. PLoS One
- Antidepressant drugs and cardiovascular pathology: a clinical overview of effectiveness and safety
- (2008) D. Taylor ACTA PSYCHIATRICA SCANDINAVICA
- Depression and Coronary Heart Disease
- (2008) Judith H. Lichtman et al. CIRCULATION
- Depressive Symptoms, Health Behaviors, and Risk of Cardiovascular Events in Patients With Coronary Heart Disease
- (2008) Mary A. Whooley JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Serum sphingomyelins and ceramides are early predictors of memory impairment
- (2008) Michelle M. Mielke et al. NEUROBIOLOGY OF AGING
- Major Depressive Disorder
- (2008) R.H. Belmaker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ceramide: A common pathway for atherosclerosis?
- (2007) Jean Bismuth et al. ATHEROSCLEROSIS
- Identification of New Functional Inhibitors of Acid Sphingomyelinase Using a Structure−Property−Activity Relation Model
- (2007) Johannes Kornhuber et al. JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation